Sir,
The paper by Yoshikawa et al (2008) is of considerable interest to our group. The authors assessed the expression of Gli-1 in the residual squamous cell carcinoma of the oesophagus in the resected specimens of the patients treated with preoperative chemoradiation. The expression of Gli-1 correlated with poor prognosis. When employing the strategy of preoperative chemoradiation in oesophageal carcinoma, the prognosis of the patients can be determined by assessing the degree of residual cancer (Chirieac et al, 2005; Wu et al, 2007). In addition, the residual cancer correlates with metastatic potential (Rohatgi et al, 2005). It would be of interest to document that Gli-1 expression has an independent prognostic value. The authors did not report a multivariate analysis. Our group first documented the expression and temporal kinetics of sonic hedgehog ligand and Gli-1 protein expression in a xenograft model using oesophageal cancer cell lines (Sims-Mourtada et al, 2006). Both biomarkers correlated with chemoradiation resistance and dynamics of tumour repopulation after chemoradiation (Sims-Mourtada et al, 2006). Furthermore, our group documented that sonic hedgehog signalling mediates chemotherapy resistance through multiple drug transporter mechanisms and that this resistance can be overcome by inhibitors of the sonic hedgehog pathway (Sims-Mourtada et al, 2007). Unfortunately, Yoshikawa et al (2008) have neglected to discuss these two publications.
References
- Chirieac LR, Swisher SG, Ajani JA, Komaki RR, Correa AM, Morris JS, Roth JA, Rashid A, Hamilton SR, Wu TT (2005) Posttherapy pathologic stage predicts survival in patients with esophageal carcinoma receiving preoperative chemoradiation. Cancer 103: 1347–1355 [DOI] [PubMed] [Google Scholar]
- Rohatgi PR, Swisher SG, Correa AM, Wu TT, Liao Z, Komaki R, Walsh G, Vaporciyan A, Lynch PM, Rice DC, Roth JA, Ajani JA (2005) Failure patterns correlate with the proportion of residual carcinoma after preoperative chemoradiotherapy for carcinoma of the esophagus. Cancer 104: 1349–1355 [DOI] [PubMed] [Google Scholar]
- Sims-Mourtada J, Izzo JG, Ajani J, Chao KS (2007) Sonic Hedgehog promotes multiple drug resistance by regulation of drug transport. Oncogene 26: 5674–5679 [DOI] [PubMed] [Google Scholar]
- Sims-Mourtada J, Izzo JG, Apisarnthanarax S, Wu TT, Malhotra U, Luthra R, Liao Z, Komaki R, van der Kogel A, Ajani J, Chao KS (2006) Hedgehog: an attribute to tumor regrowth after chemoradiotherapy and a target to improve radiation response. Clin Cancer Res 12: 6565–6572 [DOI] [PubMed] [Google Scholar]
- Wu TT, Chirieac LR, Abraham SC, Krasinskas AM, Wang H, Rashid A, Correa AM, Hofstetter WL, Ajani JA, Swisher SG (2007) Excellent interobserver agreement on grading the extent of residual carcinoma after preoperative chemoradiation in esophageal and esophagogastric junction carcinoma: a reliable predictor for patient outcome. Am J Surg Pathol 31: 58–64 [DOI] [PubMed] [Google Scholar]
- Yoshikawa R, Nakano Y, Tao L, Koishi K, Matsumoto T, Sasako M, Tsujimura T, Hashimoto-Tamaoki T, Fujiwara Y (2008) Hedgehog signal activation in oesophageal cancer patients undergoing neoadjuvant chemoradiotherapy. 98: 1670–1674 [DOI] [PMC free article] [PubMed] [Google Scholar]
